Personalized, Safe, and Effective Treatment Our team takes the time to thoroughly assess your unique health needs and medical history before recommending Myers Cocktail IV therapy
Semaglutide and tirzepatide are incretin peptides that act on entirely different receptors to influence appetite, insulin secretion, and energy balance
For a plain-language overview of how BPC-157 is currently classified from a regulatory standpoint, the U.S
Both remain investigational compounds that are not FDA-approved for any indication, and robust clinical evidence is still evolving
Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, is advancing through clinical trials with even more impressive weight loss data than tirzepatide